Clinical Trials Directory

Trials / Completed

CompletedNCT00899457

Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

Molecular Predictors of Lung Cancer Behavior: Controls

Status
Completed
Phase
Study type
Observational
Enrollment
37 (actual)
Sponsor
Vanderbilt-Ingram Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

RATIONALE: Studying samples of blood, urine, sputum, mouth cells, and bronchial tissue from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors learn more about the development of cancer. PURPOSE: This laboratory study is looking for molecular markers in predicting lung cancer development using tissue samples from healthy participants.

Detailed description

OBJECTIVES: * To obtain biological specimens from healthy participants with no known risk of lung cancer to use as controls in the study of lung cancer progression. * To identify new molecular abnormalities specific to the development of squamous cell carcinoma of the lung. OUTLINE: Serum, urine, sputum, and buccal cell samples are collected. Patients also undergo bronchoscopy for collection of bronchial tissue and bronchial brush samples. The samples are used for genomic and proteomic studies to identify new molecular abnormalities specific to the development of lung cancer.

Conditions

Interventions

TypeNameDescription
GENETICproteomic profilingCollection of tissue, blood, urine, mouth cells, spit, nasal airway cells and breath
OTHERbiologic sample preservation procedureCollection of tissue, blood, urine, mouth cells, spit, nasal airway cells and breath
OTHERlaboratory biomarker analysisCollection of tissue, blood, urine, mouth cells, spit, nasal airway cells and breath
PROCEDUREbronchoscopyCollection of breath condensate.

Timeline

Start date
2008-04-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2009-05-12
Last updated
2014-06-24

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00899457. Inclusion in this directory is not an endorsement.